5-ASA-intolerance and Increased Risk of Colectomy for UC 5-ASA-intolerance and Increased Risk of Colectomy for UC
5-aminosalicylate is first-line therapy in ulcerative colitis, but some patients cannot tolerate its side effects. Are these patients at higher risk of colectomy?Alimentary Pharmacology & Therapeutics
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Gastroenterology Journal Article Source Type: news
More News: Colectomy | Drugs & Pharmacology | Gastroenterology | Inflammatory Bowel Disease | Surgery | Ulcerative Colitis